Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

Therapnea

Financiado

Cerrado

Therapnea Novel Therapy to treat Obstructive Sleep Apnea based on Thomas Oro Ph...

Therapnea Novel Therapy to treat Obstructive Sleep Apnea based on Thomas Oro Pharyngeal Stent Obstructive sleep apnea is the most common organic sleep disorder in which the respiratory path becomes occluded during sleep, usually due to collapse of the upper airways, causing the patient to stop breathing, with severe co-mor... ver más

28/02/2018

THOMAS MEDICAL

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

THOMAS MEDICAL LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2018-02-28

SMEInst-06-2016-2017: Accelerating market introduction of...

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

THOMAS MEDICAL

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

DESARROLLO DE UN NUEVO TIPO DE DISPOSITIVO MÉ... DESARROLLO DE UN NUEVO TIPO DE DISPOSITIVO MÉDICO CPAP PAR... 465K€ Cerrado

PressureOscillations Pressure Oscillations A New Lung Therapy Approach 128K€ Cerrado

FitSleep Fabricating Non-Invasive Temporal Interference Devices for O... 150K€ Cerrado

Nyxoah Ultra small implanted neurostimulation device for the treatm... 71K€ Cerrado

AUTOMATIC DIAGNOSTIC OF OBSTRUCTIVE SLEEP APN... AUTOMATIC DIAGNOSTIC OF OBSTRUCTIVE SLEEP APNEA - ADOSA Rechazado

NEUROON-MED NEUROON MED the future of at home diagnosis of sleep disor... 2M€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2017-08-01
Fecha Fin: 2018-02-28

Líder del proyecto

THOMAS MEDICAL LTD No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Obstructive sleep apnea is the most common organic sleep disorder in which the respiratory path becomes occluded during sleep, usually due to collapse of the upper airways, causing the patient to stop breathing, with severe co-morbidity issues. Although there are several known therapies for apnea (behavioural, devices or surgery), none is as successful and effective as using compressed air respiratory support to keep the airways open during sleep, making CPAP (Continuous Positive Airway Pressure) the most common treatment of choice. Unfortunately, it still has many limitations regarding patient’s compliance, and it is ONLY SUCCESSFUL FOR 50% OF PATIENTS. According to the World Health Organisation (WHO), over 100 Million people worldwide suffer sleep apnea and its related morbidity and mortality risks. Tens of millions are unable to adhere or abandon current therapies, with CPAP as the first line of treatment. Low CPAP compliance, mainly due to major discomfort, is recognized as the major issue, and many companies are investigating ways to improve it. Sleep apnea devices market size is worth USD 8.8 billion by 2023, with 7.7% CAGR from 2016 to 2023. We at Thomas Medical Ltd. have been working on the development of a disruptive solution to respond to the unmet needs of patients that can’t adhere current therapies. The invention is an upper airway stenting device intended for the treatment of adult obstructive sleep apnea. The device, Therapnea™, operates by providing mechanical support to the walls of the pharynx and the back of the tongue, thereby preventing their collapse and eliminating partial or complete airway obstruction during sleep. We aim to provide effective therapy to the tens of millions of sleep apnea patients who can’t be helped with current CPAP devices or surgeries, and thus become the first line of treatment in the long term.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores